Need immediate assistance? Call 1-518-730-0559 (Us-Canada Toll Free) or Contact Us


Global Atrial Fibrillation Market to Receive Boost from Launch of Innovative Procedures, to Reach US$14.8 bn by 2019

Press release Description

Albany, New York, February 29, 2016: Market Research Reports Search Engine has announced that it now carries an in-depth study on the atrial fibrillation market. The report, titled “Atrial Fibrillation Market (Pharmacological and Non-Pharmacological Treatment, Electric Cardioversion, Radiofrequency, Cryo, Laser and Microwave Catheter Ablation, Maze Surgery, Anti-Coagulant and Anti-Arrhythmic Drugs) – Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 – 2019,” has been published by Transparency Market Research.

The prevalence of atrial fibrillation is on the rise, spurring healthcare agencies into action. The CDC has said that about 12 million people will be affected by atrial fibrillation by 2050. This marks a staggering rise from 2.66 million people in 2010. The growing prevalence of atrial fibrillation itself will be a high-impact growth driver for the global atrial fibrillation market, says the report. The findings of the report show that the global atrial fibrillation market will post a compound annual growth rate (CAGR) of 13.4% between 2013 and 2019. According to the report, the market for atrial fibrillation will stand at US$14.8 bn by the end of 2019.

Browse Full Global Atrial Fibrillation Market Report with TOC:

By region, the global atrial fibrillation market is segmented into: Europe, North America, Asia Pacific, and Rest of the World. In 2012, the largest regional market for atrial fibrillation in the world was North America. The high prevalence of the condition here is the reason for North America’s leading position in terms of both revenue and demand. The relative affluence of consumers in North American countries such as the United States has augured well for the growth of the atrial fibrillation market in the region. Likewise, the European market for atrial fibrillation has shown strong growth in recent years, owing to which it was identified as the second-largest regional market in 2012.

Poised for robust growth through the forecast period of the report, the Asia Pacific atrial fibrillation market will receive growing investments and is expected to be the most attractive regional market in the world. The APAC atrial fibrillation market will surge ahead thanks largely to the growing incidence of atrial fibrillation cases in China.

Basis treatment type, the report segments the global atrial fibrillation market into pharmacological and non-pharmacological treatments. The former is further segmented into: anti-arrhythmic and anti-coagulant drugs; the latter is sub-segmented into: catheter ablation, electric cardioversion, and maze surgery. The catheter ablation treatment segment is analyzed deeply by dividing it into microwave-, cryoablation-, HIFU-, radiofrequency-, and laser-based catheter ablation.

The segment of pharmacological treatment procedures was the most dominant in the global market for atrial fibrillation market as of 2012. The ubiquity and affordability of pharmacological treatments are attributable to the dominance of this segment. Most patients receiving non-pharmacological treatment are also administered pharmacological treatments in parallel. For instance, anti-coagulants may be given to a patient slated to undergo electric cardioversion or post porcedures involving catheter ablation so as to bring down the risk of stroke. Owing to this, the pharmacological atrial fibrillation procedures segment will represent an estimated 55% of the global market by 2019.

Companies that have a firm standing in the global atrial fibrillation market include: St. Jude Medical, Boston Scientific Corporation, Boehringer Ingelheim, AtriCure, Inc., Sanofi, Endoscopic Technologies, CardioFocus, and Biosense Wesbter. 

The global atrial fibrillation market is categorized into the following segments:

  • Atrial Fibrillation Market, by Treatment Types
    • Pharmacological Treatment
      • Anti-Arrhythmic Drugs
      • Anti-Coagulant Drugs
    • Non-Pharmacological Treatment
      • Catheter Ablation
        • Radiofrequency Based
        • Cryoablation Based
        • HIFU (High Intensity Focused Ultrasound) Based
        • Microwave Based
        • Laser Based
      • Maze Surgery
      • Electric Cardioversion
    • Atrial Fibrillation Market, by Geography
      • North America
      • Europe
      • Asia-Pacific
      • Rest of the World (RoW)

About Us

Market Research Reports Search Engine (MRRSE) is an industry-leading database of market intelligence reports. MRRSE is driven by a stellar team of research experts and advisors trained to offer objective advice. Our sophisticated search algorithm returns results based on the report title, geographical region, publisher, or other keywords.

MRRSE partners exclusively with leading global publishers to provide clients single-point access to top-of-the-line market research. MRRSE’s repository is updated every day to keep its clients ahead of the next new trend in market research, be it competitive intelligence, product or service trends or strategic consulting.


State Tower
90, State Street 
Suite 700 
Albany, NY – 12207 
United States

Telephone: +1-518-730-0559